An Act relating to insurance coverage for pediatric autoimmune neuropsychiatric disorders; and providing for an effective date.

HB 292 requires Alaska health insurers to cover diagnosis, treatment, and prophylaxis for pediatric autoimmune neuropsychiatric disorders (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS). It mandates coverage for specific treatments including antimicrobials, behavioral therapies, immune-related medicines, plasma exchange, and IVIG therapy. The bill prohibits insurers from denying coverage based on prior treatment, using inconsistent guidelines for immune therapies, requiring "trial" therapies before approving immune treatments, or restricting care based on age or out-of-state availability. This directly affects families with children diagnosed with PANDAS/PANS and insurers offering health plans in Alaska, ensuring equitable coverage without discriminatory practices.